Pfizer's Lewis-Hall To Represent Pharma Interests On PCORI Board
This article was originally published in The Pink Sheet Daily
Executive Summary
Freda Lewis-Hall was among nominations from both BIO and PhRMA to sit on governing board of new comparative effectiveness entity created under the health care reform law.
You may also be interested in...
PCORI Methodology Committee Member Has Interest In Cost Measures
While the legislative language that establishes the Patient-Centered Outcomes Research Institute forbids the body from using cost measures, such as dollars-per-quality adjusted life years, as a threshold in determining what type of intervention is effective or recommended, one committee member could be influential in putting a cost component into the research prioritization process.
PCORI Methodology Committee Member Has Interest In Cost Measures
While the legislative language that establishes the Patient-Centered Outcomes Research Institute forbids the body from using cost measures, such as dollars-per-quality adjusted life years, as a threshold in determining what type of intervention is effective or recommended, one committee member could be influential in putting a cost component into the research prioritization process.
Personalized Medicine Coalition Submits List Of Drug Firm Nominees For PCORI Methodology Committee
PhRMA and BIO decline to make nominations. GAO announces replacement for PCORI board.